These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
195 related items for PubMed ID: 20035818
1. Comparison of Silybum marianum (L.) Gaertn. with fluoxetine in the treatment of Obsessive-Compulsive Disorder. Sayyah M, Boostani H, Pakseresht S, Malayeri A. Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar 17; 34(2):362-5. PubMed ID: 20035818 [Abstract] [Full Text] [Related]
2. Comparison of petal of Crocus sativus L. and fluoxetine in the treatment of depressed outpatients: a pilot double-blind randomized trial. Akhondzadeh Basti A, Moshiri E, Noorbala AA, Jamshidi AH, Abbasi SH, Akhondzadeh S. Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar 30; 31(2):439-42. PubMed ID: 17174460 [Abstract] [Full Text] [Related]
5. Hydro-alcoholic extract of Crocus sativus L. versus fluoxetine in the treatment of mild to moderate depression: a double-blind, randomized pilot trial. Noorbala AA, Akhondzadeh S, Tahmacebi-Pour N, Jamshidi AH. J Ethnopharmacol; 2005 Feb 28; 97(2):281-4. PubMed ID: 15707766 [Abstract] [Full Text] [Related]
6. Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder. Riddle MA, Scahill L, King RA, Hardin MT, Anderson GM, Ort SI, Smith JC, Leckman JF, Cohen DJ. J Am Acad Child Adolesc Psychiatry; 1992 Nov 28; 31(6):1062-9. PubMed ID: 1429406 [Abstract] [Full Text] [Related]
9. Mirtazapine for obsessive-compulsive disorder: an open trial followed by double-blind discontinuation. Koran LM, Gamel NN, Choung HW, Smith EH, Aboujaoude EN. J Clin Psychiatry; 2005 Apr 28; 66(4):515-20. PubMed ID: 15816795 [Abstract] [Full Text] [Related]
10. Memantine add-on in moderate to severe obsessive-compulsive disorder: randomized double-blind placebo-controlled study. Ghaleiha A, Entezari N, Modabbernia A, Najand B, Askari N, Tabrizi M, Ashrafi M, Hajiaghaee R, Akhondzadeh S. J Psychiatr Res; 2013 Feb 28; 47(2):175-80. PubMed ID: 23063327 [Abstract] [Full Text] [Related]
15. Crocus sativus L. (petal) in the treatment of mild-to-moderate depression: a double-blind, randomized and placebo-controlled trial. Moshiri E, Basti AA, Noorbala AA, Jamshidi AH, Hesameddin Abbasi S, Akhondzadeh S. Phytomedicine; 2006 Nov 28; 13(9-10):607-11. PubMed ID: 16979327 [Abstract] [Full Text] [Related]
16. Predictors of drug treatment response in obsessive-compulsive disorder. Ravizza L, Barzega G, Bellino S, Bogetto F, Maina G. J Clin Psychiatry; 1995 Aug 28; 56(8):368-73. PubMed ID: 7635854 [Abstract] [Full Text] [Related]
17. Low-dose risperidone augmentation of fluvoxamine treatment in obsessive-compulsive disorder: a double-blind, placebo-controlled study. Erzegovesi S, Guglielmo E, Siliprandi F, Bellodi L. Eur Neuropsychopharmacol; 2005 Jan 28; 15(1):69-74. PubMed ID: 15572275 [Abstract] [Full Text] [Related]
18. Efficacy of long-term fluoxetine treatment of obsessive-compulsive disorder. Frenkel A, Rosenthal J, Nezu A, Winston A. Mt Sinai J Med; 1990 Nov 28; 57(6):348-52. PubMed ID: 2079952 [Abstract] [Full Text] [Related]
19. Obsessive compulsive disorder, depression, and fluoxetine. Hollander E, Mullen L, DeCaria CM, Skodol A, Schneier FR, Liebowitz MR, Klein DF. J Clin Psychiatry; 1991 Oct 28; 52(10):418-22. PubMed ID: 1938978 [Abstract] [Full Text] [Related]